Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0364020070400040292
Korean Journal of Thoracic and Cardiovascular Surgery
2007 Volume.40 No. 4 p.292 ~ p.296
Treatment of Primary Spontaneous Pneumothorax Using a Commercialized 8-French Catheter (Pleuracan¨Þ)
Park Jung-Sik

Lee Jae-Ik
Hwang Yeo-Ju
Park Kook-Yang
Park Chul-Hyun
Jeon Yang-Bin
Choi Chang-Hyu
Abstract
Background: This retrospective study was undertaken to assess the effectiveness of the 8-French (Fr) catheter (Pleuracan¨Þ) for the initial treatment of primary spontaneous pneumothorax.

Materials & Methods: Between July 2004 and July 2006, 59 patients (72 cases) underwent a closed thoracostomy for primary spontaneous pneumothorax. We divided these patients into two groups: group T (large bore (£¾20 Fr) chest tube group) and group P (Pleuracan¨Þ group).

Results: Initially, the Pleuracan¨Þ catheters were inserted in 41 cases. There were four catheter malfunctions (9.8%); three cases had a subsequent closed thoracostomy with a large bore chest tube. Ultimately, there were 34 cases in group T and 38 cases in group P. There were no significant differences in indwelling catheter time (T: 2.1¡¾1.5 days, P: 2.1¡¾1.3 days), hospital stay (T: 6.4¡¾5.4 days, P: 5.2¡¾2.9 days) and complications (T: 3%, P: 0%) between the two groups. The percentage of cases that needed intravenous analgesics in group P was 60% (23/38); this was significantly lower than the number for group T (90%, 31/34) (p=0.003). In a subgroup of patients that did not undergo bullectomy (T: 17 cases, P: 19 cases), there were no significant differences in the duration of air leakage (T: 0.5¡¾0.7 days, P: 0.5¡¾1.2 days) and in the percentage of patients with complete lung re-expansion (T: 94%, P: 84%) between the two groups.

Conclusion: Application of the Pleuracan¨Þ catheter for the initial treatment of primary spontaneous pneumothorax was as effective as the large bore chest tube.
KEYWORD
Pneumothorax, Catheter, Thoracostomy
FullTexts / Linksout information
  
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø